Yaskawa Motoman has released a new interface supporting NI LabVIEW programming of Motoman industrial robots. Developed in collaboration with National Instruments and ImagingLab, the library allows ...
Post-baccalaureate Readiness Instruction for bioMedical Education (PRIME) Certificate MS in Applied Anatomy MS in Medical Physiology MS in Molecular & Cellular Biology of Disease No matter which ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback